| [1] |
Tampaki M, Gatselis NK, Savvanis S, et al. Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers. Eur J Gastroenterol Hepatol, 2020.Online ahead of print.
|
| [2] |
Gitlin JD.Wilson disease. Gastroenterology, 2003,125:1868-1877.
|
| [3] |
Sanchez-Monteagudo A, Alvarez-Sauco M, Sastre I, et al.Genetics of Wilson disease and Wilson-like phenotype in a clinical series from eastern Spain. Clin Genet, 2020,97:758-763.
|
| [4] |
Czlonkowska A, Litwin T, Dusek P, et al.Wilson disease. Nat Rev Dis Primers, 2018,4:21.
|
| [5] |
Stattermayer AF, Entenmann A, Gschwantler M, et al.The dilemma to diagnose Wilson disease by genetic testing alone. Eur J Clin Invest, 2019,49:e13147.
|
| [6] |
European Association for Study of L. EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol, 2012,56:671-685.
|
| [7] |
Reeve JL, Frayling IM, Twomey PJ.Challenges in molecular diagnosis of Wilson disease. J Clin Pathol, 2020,73:181-182.
|
| [8] |
Czlonkowska A, Rodo M, Gromadzka G.Late onset Wilson's disease: therapeutic implications. Mov Disord, 2008,23:896-898.
|
| [9] |
Coffey AJ, Durkie M, Hague S, et al.A genetic study of Wilson's disease in the United Kingdom. Brain, 2013,136:1476-1487.
|
| [10] |
Collet C, Laplanche JL, Page J, et al.High genetic carrier frequency of Wilson's disease in France: discrepancies with clinical prevalence. BMC Med Genet, 2018,19:143.
|
| [11] |
Gao J, Brackley S, Mann JP.The global prevalence of Wilson disease from next-generation sequencing data. Genet Med, 2019,21:1155-1163.
|
| [12] |
Jang JH, Lee T, Bang S, et al.Carrier frequency of Wilson's disease in the Korean population: a DNA-based approach. J Hum Genet, 2017,62:815-818.
|
| [13] |
Cooper DN, Krawczak M, Polychronakos C, et al.Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet, 2013,132:1077-1130.
|
| [14] |
Zlotogora J.Penetrance and expressivity in the molecular age. Genet Med, 2003,5:347-352.
|
| [15] |
Stapelbroek JM, Bollen CW, van Amstel JK, et al. The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis. J Hepatol, 2004,41:758-763.
|
| [16] |
McCann CJ, Jayakanthan S, Siotto M, et al. Single nucleotide polymorphisms in the human ATP7B gene modify the properties of the ATP7B protein. Metallomics, 2019,11:1128-1139.
|
| [17] |
Bucossi S, Polimanti R, Mariani S, et al.Association of K832R and R952K SNPs of Wilson's disease gene with Alzheimer's disease. J Alzheimers Dis, 2012,29:913-919.
|
| [18] |
Ala A, Borjigin J, Rochwarger A, et al.Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology, 2005,41:668-670.
|
| [19] |
Mordaunt CE, Shibata NM, Kieffer DA, et al.Epigenetic changes of the thioredoxin system in the tx-j mouse model and in patients with Wilson disease. Hum Mol Genet, 2018,27:3854-3869.
|
| [20] |
Schiefermeier M, Kollegger H, Madl C, et al. The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain, 2000,123 Pt 3:585-590.
|
| [21] |
Litwin T, Gromadzka G, Czlonkowska A.Apolipoprotein E gene (APOE) genotype in Wilson's disease: impact on clinical presentation. Parkinsonism Relat Disord, 2012,18:367-369.
|
| [22] |
Bandmann O, Weiss KH, Kaler SG.Wilson's disease and other neurological copper disorders. Lancet Neurol, 2015,14:103-113.
|
| [23] |
Roy S, Ganguly K, Pal P, et al.Influence of apolipoprotein E polymorphism on susceptibility of Wilson disease. Ann Hum Genet, 2018,82:53-59.
|
| [24] |
de Bie P, van de Sluis B, Burstein E, et al. Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B. Gastroenterology, 2007,133:1316-1326.
|
| [25] |
Ferenci P, Stremmel W, Czlonkowska A, et al.Age and sex but not ATP7B genotype effectively influence the clinical phenotype of Wilson Disease. Hepatology, 2019,69:1464-1476.
|
| [26] |
Kasai N, Miyoshi I, Osanai T, et al.Effects of sex hormones on fulminant hepatitis in LEC rats: a model of Wilson's disease. Lab Anim Sci, 1992,42:363-368.
|
| [27] |
Mordaunt CE, Kieffer DA, Shibata NM, et al.Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers. Epigenet Chromatin, 2019,12:10.
|
